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Abstract
Identification of a critical gene in the dihydroergot alkaloid pathway
Yulia Bilovol
Ergot alkaloids, bioactive compounds produced by some species of fungi, have had significant
impacts on agriculture and medicine. Claviceps purpurea and Epichloë spp. are ergot alkaloid
producers associated with agricultural commodities and negatively affect humans and grazing
animals, respectively. Another ergot alkaloid-producing fungus called Aspergillus fumigatus is
ubiquitous in the environment; infections arising after inhaling the spores may kill
immunocompromised persons. Ergot alkaloids and their derivatives are utilized by the
pharmaceutical industry for the development of drugs. Some of these drugs are derived from
lysergic acid, whereas others are derived from dihydrolysergic acid. Lysergic acid derivatives
have vasoconstrictive properties and are used as treatment of acute headaches and in obstetrics.
Dihydrolysergic acid derivatives are vasorelaxant and are the basis of drugs that help treat
dementia, Alzheimer’s, and Cushing’s diseases. The ergot alkaloid pathway has largely been
elucidated, but unknown steps remain, particularly in the dihydrolysergic acid branch. The gene
encoding the enzyme that oxidizes festuclavine, a key intermediate in the dihydrolysergic acid
branch, to fumigaclavine B is unknown. Based on DNA sequence analysis, we hypothesized that
the A. fumigatus gene easM encodes this enzyme. To test this hypothesis we knocked out easM
by inserting a hygromycin resistance gene in the middle of its coding sequence and transforming
A. fumigatus with this construct. HPLC analysis showed that knock out of easM blocked the
ergot pathway at festuclavine, and three downstream products (fumigaclavines B, A, and C) were
eliminated. PCR results showed the hygromycin resistance fragment was present in the middle of
easM-coding sequences in these transformants. Complementation, or reintroduction of the native
non-disrupted easM gene restored the ability of the fungus to produce all downstream
compounds. These results indicate that easM encodes the enzyme that oxidizes festuclavine to
fumigaclavine B. The festuclavine-accumulating strain of A. fumigatus will be instrumental in
future studies investigating the biosynthesis of dihydrolysergic acid derivatives, which are
derived from festuclavine and are the basis for important vasorelaxant drugs.
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1 Overview
Ergot alkaloids are bioactive compounds that can be produced by several different
species of fungi in the families Clavicipitaceae and Trichocomaceae. These fungi, collectively,
can be found in a variety of environments. Some can live as saprotrophs, whereas others can
infect a variety of hosts, including grasses and cereals, or humans and animals. The ergot
alkaloid pathway for all ergot alkaloid-producing fungi appears to be shared in the early steps,
but their divergence at the chanoclavine-I aldehyde branch point (Figure 1) leads to unique end
products that are dependent upon the species of fungus producing them (Panaccione et al. 2012).
Typical products of these pathways include clavines and lysergic acid derivatives. The
synthesized chemicals are pertinent in medicine, as they are used in pharmaceuticals, and are of
concern in agriculture due to their effect on grazing animals. Ergot alkaloid biosynthesis has
been well studied but a few unknown steps remain thus, further understanding of these
compounds can be of benefit for applications in medicine and agriculture in the future.

1.1 History and significance
Ergot alkaloid-producing fungi established their significance throughout history.
Agricultural notoriety took root when grain crops, particularly rye, infected with Claviceps
purpurea caused products made from the infected cereals to be unsafe to eat. A hard black
structure called a sclerotium replaces seed within the flowering portion of the grass and was
processed as grain until its deleterious effects were discovered. The mycotoxins produced within
these hard overwintering structures are able to survive baking temperatures and digestive
conditions, thus making them tenacious toxins (Merkel et al. 2012). Ergot poisoning or ergotism
causes a variety of symptoms from hallucinations to gangrene of the extremities and convulsions
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(Belser-‐Ehrlich et al. 2013). “St. Anthony’s fire” or ignis sacer derives its name from the burning
sensations occurring in the extremities due to the vasoconstrictive activities of ergot alkaloids
ingested from ergot-infected grains. Ergotism left such an impression on history that renaissance
painters like Matthias Grünewald and Hieronymus Bosch immortalized the disease through art.
Fortunately, the diversification of diets and processing or screening of grain has largely
alleviated ergotism’s threat to consumers. Belser-Ehrlich et al. (2013) chronicle the major
outbreaks of ergotism in humans since 1900 occurring in Russia in 1926-1927, England in 1927,
Ireland in 1929, France in 1951, India in 1956-1957 and 1975, and Ethiopia in 1977-1978 and
2001. Luckily these outbreaks have not been equal in magnitude to those of the Middle Ages,
and they were confined to remote areas or countries where regulations are not rigorous. Current
regulations in developed countries around the world limit the amount of ergot that can be
consumed by humans; for example, in the US the limit for ergot presence in rye cannot exceed
0.3 percent (Code of Federal Regulations 2001) and is lower for other products like oats, wheat,
and barley.
Deleterious effects from ergot-producing fungi may also be experienced by livestock
ingesting contaminated grasses or feed. Epichloë species, grass symbionts capable of producing
ergot alkaloids, have been known to cause grazing livestock to experience unfavorable
symptoms including vasoconstriction at the extremities resulting in gangrene (Schardl et al.
2006). Epichloë endophytes are known to produce four classes of alkaloids: ergot alkaloids
(lysergic acid and ergovaline), indolediterpenes, pyrrolopyrazine, and aminopyrrolizidines that
act as insecticidal compounds. Among these four classes, ergot alkaloids and indolediterpenes
can affect vertebrates (Schardl and Phillips 1997). Coupled with environmental conditions, ergot
toxicosis has varying effects on livestock. For example in heat stress conditions, animals that
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ingest the toxins lose control of body temperature, water balance, experience necrosis of adipose
tissue, and have the tendency to eat less food. Ingestion of toxins in cold conditions leads to
gangrene. In general, toxin ingestion causes a reduction of lactation and fertility and, particularly
in horses, miscarriages, fetal abnormalities, and stillbirths (Schardl and Phillips 1997). Economic
losses due to livestock toxicosis may be ameliorated by using genetic techniques targeting toxin
producing genes of mycobionts. Genetic engineering techniques are being explored, but since
endophytes benefit their plant hosts, special attention needs to be paid to the acuteness of
toxicosis in animals and environmental and genetic factors in selecting agronomically desirable
endophytes that will maintain their endophyte niche but will not harm grazing livestock. Thus,
there is still much to be explored regarding the control of toxin producing endophytes.
Ergot alkaloids’ effects on history were not all negative; people have attempted to
harness their biological activities for religious ceremonies and medicinal applications. In ancient
Aztec cultures, priests would eat morning glory seeds with their associated alkaloid producing
endophytes to induce psychoactive effects as a means of communication with the gods
(Hofmann, Rätsch, & Schultes 1992). Albert Hoffman was the research chemist responsible for
the discovery of lysergic acid diethylamide (LSD) and also investigated the psychoactive effects
of seed endophytes and hallucinogenic mushrooms eaten in South America (Hoffman 1980). His
studies indicated that the chemicals lysergic acid amide, ergonovine, and lysergic acid
hydroxyethylamide (the main active component in the preparations ingested by the indigenous
people of South America) are closely chemically related to LSD. Beyond the psychoactive
effects, lysergic acid derivatives act on smooth muscle tissues which is why midwives in the
Middle Ages utilized ergot alkaloids to aid in child birth; however, because concentrations of
alkaloid were difficult to control in preparations and often caused complications they eventually
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fell out of use (Tudzynski, Correia, & Keller 2001). With time, more became known about
alkaloid activities and with it the ability to control dosage. Alkaloids began being incorporated
into headache medications and a host of other drugs on the market today.

1.2 Ergot alkaloid-producing organisms
Aspergillus fumigatus is a common saprophyte in the phylum Ascomycota. A. fumigatus
plays a role in an agricultural aspect: it spoils stored crops, such as animal feed especially in
warm, moist conditions (Scudamore & Livesey 1997). A. fumigatus is ubiquitous due to its key
role in environmental decay; thus, it can be found at especially high concentrations around
composting facilities and other areas where there is a large amount of decomposing matter. A.
fumigatus conidia are minute and very buoyant (Panaccione and Coyle 2005) allowing them to
travel great distances, aiding the organism in spread and infection. The presence of A. fumigatus
in air has been associated with respiratory ailments and allergic symptoms in humans. In
immunocompromised persons it may manifest as invasive aspergillosis or systemic spread of
infection, with a mortality rate of more than fifty percent. In healthy individuals, the immune
system will typically clear the infection, but in some cases the fungus may colonize cavities
within lung tissue or sinuses resulting in aspergilloma or fungus ball (Denning 1998).
A. fumigatus synthesizes alkaloids called clavines, or more particularly festuclavine,
fumigaclavine A, fumigaclavine B, and fumigaclavine C, with fumigaclavine A or fumigaclavine
C typically occurring as the end product in the pathway (Robinson and Panaccione 2012).
Alkaloid production is associated with asexual reproduction, with alkaloid metabolites localized
in the conidia (Coyle et al. 2007). Aspergillus fumigatus is an ideal candidate for the study of
ergot alkaloid biosynthesis because it grows quickly in the saprophytic state in vitro yielding
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measureable amounts of chemical. Its genome has also been sequenced, with numerous studies
investigating genes within the ergot alkaloid gene cluster through knockout and
complementation studies. Resulting knockout strains are important for serving as recipients for
the expression of ergot alkaloid synthesizing genes of other fungi. This study follows suit with
the knockout and complementation of a gene with an unassigned role in the ergot alkaloid gene
cluster. Future studies will be able to utilize the knockout strain of A. fumigatus as a recipient for
a gene of interest in an attempt to understand dihydroergot alkaloid biosynthesis.
Epichloë spp. (formally Neotyphodium spp.) are another genus of fungi in the family
Clavicipitaceae that produce ergot alkaloids; they are grass symbionts that colonize above
ground portions of plants, growing in the intercellular spaces. Tall fescue and perennial rye grass
are two of the most commonly studied grasses relating to Epichloë spp. as symbionts. Symbiotic
or endophytic relationships between grasses and Epichloë species are seed transmissible (Bacon
& White 2000) meaning that the symbiotic fungus not only grows in the intercellular spaces of
the plant but that it will grow into the developing seed for the purpose of dispersal and
colonization when the new seed germinates. The mutualism provides the plant with drought
tolerance, enhanced photosynthetic rate, and growth (Clay & Schardl 2002). Ergot alkaloid
production in plants has also been shown to deter herbivory; a study found that rabbits preferred
to eat grasses colonized by endophytic fungi that were alkaloid free versus grasses containing
alkaloids or even endophyte-free grasses (Panaccione et al. 2006). Additionally, it has been well
documented that biologically active alkaloids of the fungus have insecticidal activities,
conferring protection to its host and increasing its competitiveness (Schardl et al. 2004). The
lysergic acid derivatives produced by Epichloë spp. cause livestock feeding on these grasses to
experience detrimental effects such as poor fertility, convulsions, poor weight gain, gangrene,
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and even death (Schardl & Phillips 1997). Studying alkaloid producing endophytes is worthwhile
to understand how they can be better managed out in the field to decrease their effects on the
economic loses pertaining to grazing animals.

1.3 Ergot alkaloid cluster, pathway, and unknown steps
Ergot alkaloid synthesizing genes are found in clusters; however, the clusters vary
depending on the organism (Figure 2). Genetic variation within clusters between species allows
for the rich diversity in the ergot alkaloid pathway allowing some species to produce lysergic
acid derivatives, dihydrolysergic acid derivatives, ergopeptines, or fumigaclavines (Figures 1 &
3). Arrangement of genes, variation in coding sequences for alleles, and even the presence or
absence of some genes within clusters vary, and may be observed via sequencing of the ergot
alkaloid clusters (Figure 2) (Schardl et al. 2013; Coyle and Panaccione 2005). For example,
genes unique to the A. fumigatus cluster (easN, and easL,) are responsible for the production of
different fumigaclavines (Figure 4). All of these genes have been sequenced, but some of their
roles have not yet been assigned; this is the primary focus of this study.
Early steps in the ergot alkaloid synthesis pathway are evolutionarily conserved among
alkaloid producing fungi (Figure 3). An early step in the ergot alkaloid pathway is the
prenylation of tryptophan by DMATrp synthase, coded by the dmaW gene. Genetic and
biochemical analyses demonstrated that it is the determining step in the ergot pathway for A.
fumigatus (Coyle and Panaccione 2005). Knockout of dmaW in A. fumigatus completely
eliminated all ergot alkaloids from the mutant, and the complementation restored production.
The next important feature of the pathway is the chanoclavine-I aldehyde intermediate, at which
the pathway diverges and varying terminal branch products are made according to individual
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producers (Panaccione et al. 2012). Understanding which genes are responsible for each step in
these pathways is critical for the study of the biosynthesis of the biologically important end
products. Investigation of one of the remaining unknown steps, for which easM is hypothetically
responsible, will help complete the pathway for the production of fumigaclavines in A. fumigatus
and will be instrumental for future research of dihydroergot alkaloid biosynthesis.

1.4 Justification for choosing easM as a target gene
One of the few remaining unknown steps in fumigaclavine synthesis for A. fumigatus is
the oxidative step responsible for modifying festuclavine into fumigaclavine B. Two candidate
genes for this step are easM and easK, which are located in the ergot alkaloid gene cluster
(Figures 2 & 4) and for which roles have not yet been assigned. Two pieces of evidence used to
choose easM as the candidate gene for this study were as follows. First, the proposed structure
for the protein coded by easM indicates that it is a P450 monooxygenase (Panaccione 2010).
This putative function aligns well with the activity required to convert festuclavine to
fumigaclavine B, which differs only by the presence of a hydroxyl group. Second, comparative
genomics of A. fumigatus with Penicillium commune, organisms with similar clusters and similar
ergot alkaloid profiles, indicates that the presence of easM and not easK correlates with the
ability to produce ergot alkaloids (Panaccione 2010; Coyle & Panaccione 2005; Wallwey and Li
2011). Both easM and easK are present in A. fumigatus but P. commune only has easM while
still retaining the ability to produce alkaloids (Wallwey and Li 2011). This leads us to
hypothesize that easK is not essential for alkaloid production or that it may be redundant with
easM. Both of these clues suggest that easM is the responsible gene for festuclavine oxidation to
fumigaclavine B.
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1.5 Benefits of research – agricultural and pharmaceutical implications
Pharmaceutically, derivatives of the ergot alkaloid pathway are important because they
can be incorporated into drugs. Ergot alkaloids are similar in molecular structure to
neurotransmitters that interact with serotonin, dopamine, adrenaline, and neurodreneline
receptors (Belser-‐Ehrlich et al. 2013; Panaccione 2011). These similarities are attributed to the
psychoactive and/or vasoconstrictive or relaxant properties associated with these mycotoxins.
Mycotoxin agonism for serotonin-2A receptors is thought to be responsible for the
hallucinogenic properties of ergot alkaloids (Vollenweider et al. 1998). Vasoconstrictive
symptoms in the extremities are linked to alkaloids interacting with serotonin-1B/D receptors
(Anderson et al. 1987). Vasoconstrictive properties of lysergic acid derivatives have been used to
induce labor, terminate postpartum bleeding, and mimic dopamine (Hoffman 1980). Lysergic
acid derivatives are currently ingredients in drugs that treat type II diabetes (Via et. al. 2010) and
act as neurotransmitter agonists (Cabergoline) for treatment of pituitary disorders like
Parkinson’s disease. It is important to note that because alkaloids have affinities for many
receptors and can act as agonist or antagonists, their biological activities are not simple and often
associated with many side-effects (Panaccione 2010).
Dihydrolysergic acid derivatives differ from lysergic acid derivatives in that they lack a
double bond in their D ring (Figure 5) and thus have vasorelaxant effects, opposite of those
produced by lysergic acid derivatives. Dihydrolysergic acid derivatives are used in the treatment
of disorders like dementia (Nicergoline) (Fioravanti & Flicker 2001), Alzheimer’s, and
Cushing’s disease (Bracco et al. 2004). Patients with frequent, moderate headaches may receive
a prescription from their provider for a nasal spray or injection called Migranal® a
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dihydroergotamine (Valeant Pharmaceuticals, QC, Canada); tablets may also be available under
the name Ergomar® and contain ergotamine (Rosedale Therapeutics, TN, USA) (Reddy 2013).
Thus, the production of dihydrolysergic acid by a novel fungus may have agricultural and
pharmaceutical benefits. Dihydrolysergic acid-producing fungi in agriculture may counteract the
vasoconstrictive effects of natural Epichloë-infected grasses. The development of a more
efficient process for attaining dihydrolysergic acid, via biosynthesis rather than chemically, can
be beneficial to the pharmaceutical industry by lowering costs.

2 Study Objectives
This study will elucidate an unknown step in fumigaclavine synthesis in A. fumigatus. I
will test the hypothesis that the product of easM is necessary for oxidizing festuclavine to
fumigaclavine B. One potentially significant outcome of this work would be the production of a
strain of A. fumigatus that can be used for further studies on the biosynthesis of dihydrolysergic
acid.

3 Materials and methods
3.1 Knockout construct preparation
The easM gene was PCR amplified from A. fumigatus template DNA in a reaction
primed with easM forward and easM reverse primers (Table 1, Figure 6A). The EasM reaction
consisted of 25 µL mixture containing: 1 X GoTaq Flexi buffer (Promega, Madison, WI), 1.5
mM MgCl2, 200 µM each deoxynucleotide triphosphate, 1 µM of each designated primer, and
2.5 units GoTaq Flexi DNA polymerase (Promega, Madison, WI). The thermocycler program
that carried out the procedure began with a denaturation step at 95°C for 3 minutes, then 35
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cycles of: 95°C for 30 seconds, 55°C for 30 seconds, and 72°C for 3 minutes, and ending with a
final extension of 72°C for 5 minutes. The easM fragment is 3,067 bases long, the length of
which was confirmed by gel electrophoresis (Figure 6). The easM fragment was then ligated into
plasmid pCR 2.1 to obtain a more concentrated product, and the ligation was transformed into
Escherichia coli. E. coli colonies were grown on ampicillin-containing medium to select plasmid
containing colonies. The presence of easM in the plasmid was determined by PCR primed with
easM forward and easM reverse primers, in the same PCR program as described above. The
product was then cleaned using a QIAquick column (Qiagen, Gaithersburg, MD).
To disrupt the easM coding sequence in the plasmid, it was digested with restriction
enzymes SmaI and ClaI which cut out 1,091 bases located in the middle of the 3,067 base pair
sequence of easM. The 1,443 base pair hygromycin resistance gene was amplified from template
pCB1004 in a PCR reaction primed with SmaHygF and ClaHygR using the same thermocycler
program as described above; recognition sites for SmaI and ClaI were included in the 5’ ends of
these primers and were used to introduce the hygromycin-resistance fragment into the gap of the
easM plasmid by ligating the SmaI-ClaI cut hygromycin resistance fragment with the SmaI-ClaI
cut easM-pCR 2.1 plasmid. The ligation was then transformed into E. coli and the resulting
colonies were screened for the correct fragment via PCR using easM forward and reverse
primers to visualize the 3,417 bp fragment of disrupted easM with the hygromicin fragment in
the middle (Figure 6). As an additional check the fragment was digested again with restriction
enzymes SmaI, ClaI, EcoRI to visualize that the cut portions corresponded to the predicted sizes.
The insert of the final plasmid sample was amplified by PCR using easM forward and easM
reverse primers and Phire Hot Start II polymerase (Thermo-Fisher Scientific, Waltham, MA) in a
program starting with a 98°C denaturation for 30 seconds, followed by 35 cycles of: 98°C for 15
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seconds, 65°C for 15 seconds, with a final extension at 72°C for 1 minute. The product was then
cleaned using QIAquick column (Qiagen, Gaithersburg, MD).

3.2 Fungal transformation and complementation
The easM-HYG fragment was transformed into A. fumigatus by established methods
(Coyle and Panaccione 2005) and grown on hygromycin selective medium. Only cells that took
up the easM-hygromycin knockout construct were able to grow since they had the hygromycin
resistance gene (Figure 6A).
To start the culture for transformation, A. fumigatus strain Af293 was grown on malt
extract agar for approximately three days. Then, 10 mL of malt extract broth was used to create a
spore suspension which was subsequently inoculated into an additional 20 mL of malt extract
broth in a 50 mL flask and incubated overnight (approximately 16 hours) on an orbital shaker at
37°C and 80 rpm. Mycelium was pelleted in a 30-mL Nalgene Oak Ridge tube. Protoplasts were
prepared by suspending the mycelial pellet in 15 mL of 0.7 M NaCl, 40 mg lysing enzyme
(Sigma-Aldrich, Saint Louis, MO), and 1 g VinoTaste Pro (Novozymes, Switzerland) and
allowing the mixture to incubate at 30°C for two hours. Protoplasts were separated from debris
via filtration through a Miracloth (Calbiochem, San Diego, CA) funnel. Protoplasts were then
washed by successively centrifuging (3,000 rpm for 5 min) and resuspending in the following
solutions: 10 mL 0.7 M NaCl, 5 mL STC (1M sorbitol, 50 mM tris-Cl pH 7.4, 50 mM CaCl2),
and finally several hundred uL of STC to achieve protoplast concentration of 5x106 protoplasts
per 100 uL. A solution of two parts 60% polyethylene glycol (PEG) and one part PEG
amendments (1.8 M KCl, 150 mM CaCl2, 150 mM Tris pH 7.4) was then added to comprise 1/5
of the volume. Aliquots of 125 µL of protoplast-PEG solution were added to 1.5 mL sterile
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tubes, along with 10 µL of the easM knockout construct and then incubated on ice for 30
minutes. An additional 1 mL of PEG solution was added, the mixture was incubated at room
temperature for 20 minutes and then plated onto Hygromycin (InvivoGen, San Diego, CA)
selective medium.
A complementation assay was carried out to demonstrate that the phenotype of the easM
knockout was due to the disruption at easM and not some other unrelated mutation in the colony.
The wild-type allele of easM was first amplified from easM forward and easM reverse primers
with Phire polymerase. The PCR product was cleaned up using Qiagen (Qiagen, Gaithersburg,
MD) clean up kit. Next, a transformation was performed, as described above with Phleomycin
(InvivoGen, San Diego, CA) resistance conferred by pBCphelo as the selectable marker onto
Phleomycin (InvivoGen, San Diego, CA) selective medium.

3.3 PCR analysis of transformants
DNA preparations from each strain (wild type, easM knockout, and easM complemented)
were checked via three PCR assays (Figure 6B). A wild-type screen primed with the easM
forward and easM reverse primers checked for the size of the allele at the easM locus. A three
prime screen with easNtowardM with YG primers checked for presence of the 3’ portion of
easM adjacent to the hygromycin resistance gene. A five prime screen based on easDinF with
HY primers checked for the presence of the 5’ portion of easM adjacent to the hygromycin
resistance gene.

12	
  
	
  

	
  

3.4 Alkaloid analysis
To investigate the types of ergot alkaloids that accumulated in transformants, samples
were analyzed by high performance liquid chromatography (HPLC) with fluorescence detection
and liquid chromatography mass spectrometry (LC/MS).
Six replicate plates of A. fumigatus Af293 wild type, easM knockout, and easM
complemented were grown on malt extract agar for two weeks. Cultures were extracted by
removing a ~50 mm2 sample area via the wide end of 1,000-µL pipette tip and suspending it in
HPLC-grade methanol for an hour, rotating on a carousel. After centrifugation, supernatant (20
µL) of the extraction was analyzed via reverse phase HPLC. Samples were separated via C18
column (Phenomenex Prodigy ODS3, 5-µm particle size, Torrence, CA). Ergot alkaloids were
quantified by comparing peak areas to a standard curve of dihydroergotamine and normalizing to
number of conidia extracted. Conidia in each extract were counted with the aid of a
hemocytometer.
The uncharacterized chemical detected via HPLC eluting from the column at 55.9
minutes was explored with the aid of a Thermo Fisher LCQ DecaXP LC/MS. Six replicates of A.
fumigatus Af293 wild type, easM knockout, and easM complemented were grown on malt agar
plates for two weeks. Spores were suspended in 5 mL HPLC grade methanol and scraped from
the agar plates with a spreader. Spores were allowed to spin on a carousel for three hours and
then were centrifuged for ten minutes. Each sample yielded slightly over one mL of extract
which was subsequently concentrated to 100 µL in a vacuum centrifuge. Of the resulting
concentrate, 10 µL was then loaded to be analyzed by LC/MS. LC/MS analyses were conducted
as described by Ryan et al. (2013).
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3.5 Statistical analysis
Alkaloid concentrations were analyzed statistically with JMP software (SAS, Cary, NC)
A Brown–Forsythe test was used to determine equality of group variances with F > 0.05 level.
With equality of variances determined, an ANOVA was then used to compare quantities of each
alkaloid among strains, with p<0.05 indicating that chemical concentration varied by strain. This
indication allowed for the subsequent Turkey-Kramer HSD test, to compare pairs to find
significantly different means. Results reported in Table 2 display mean alkaloid concentrations ±
standard error. Letters A, B, or AB within each column indicate the results of the Tukey-Kramer
test, with same letters showing no difference between strains and different letters indicating a
statistically significant difference

4 Results
To test the hypothesis that easM is required for oxidation of festuclavine, easM was
knocked out by replacing a large part of its coding sequences with a hygromycin resistance gene
(Figure 6A). A complementation procedure was then carried out to restore the chemical profile
and confirm easM function.

4.1 easM knockout
The native copy of easM in A. fumigatus was successfully knocked out through
homologous recombination with the inactivated easM-HYG construct. Of the 54 transformant
samples tested by HPLC, 12 showed an accumulation of festuclavine (the intermediate preceding
the hypothesized EasM step) and loss of fumigaclavine C, the pathway end product (Figure 7).
An unknown chemical, eluting from the column at 55.9 minutes, also appeared to be affected by
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the easM knock out (Figure 7). Its identity was investigated via liquid chromatography mass
spectrometry (LC/MS) in which a molecular ion of m/z 309.3 was detected (Figure 8). This
molecular ion is consistent with the [M+H]+ for prenylated festuclavine, an alkaloid previously
detected in A. fumigatus and named 9-deacetoxyfumigaclavine C by Ge et al. (2009).
Three types of PCR assays showed that the easM-HYG knockout construct was, in fact,
integrated at the easM locus. The first assay was primed with oligonucleotides flanking the
intended site of integration (Fig. 6B). The fragment obtained from the easM knockout (KO) was
larger than that obtained from the wild type (WT) A. fumigatus due to the replacement of a
portion of the easM coding sequences with the hygromycin resistance genes (Figure 6A). The
second (5’ screen) and third (3’ screen) assays were each conducted with one primer that flanked
the 5’ or 3’ end of easM, respectively, and a second primer that annealed to the hygromycinresistance gene (Figure 6A). The samples showed predicted size bands for each screen (Figure
6). This indicated that the wild type sample contained a functional copy of easM as expected, the
knockout strain contained the easM-HYG construct which was integrated during fungal
transformation, and that the complemented strain contained both the easM and easM-HYG
fragments.

4.2 easM complementation
To demonstrate that phenotype of the easM knockout was due to the integration at easM
and not any ectopic events, the easM knockout strain was complemented in trans with the wildtype allele of easM. Complementation resulted in restoration of the wild-type alkaloid profile in
a qualitative sense (Figure 7). Integration of the complementing easM fragment was confirmed
via PCR (Figure 6B). The presence of a fragment of wild-type length in the assay primed with
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easM forward and easM reverse primers indicated the incorporation of the wild-type allele,
whereas the presence of the longer fragment (typical of the easM knockout strain) indicated that
the complementing allele had integrated ectopically. Thus the primers amplified the easM wildtype copy as well as the easM-HYG construct at the previously knocked out easM locus,
resulting in fragments of 3 kb and 3.4 kb, respectively. Ectopic integration of the complementing
allele also was supported by the observation of fragments typical of the knockout locus in the 5’
flank and 3’ flank PCR assays (Figure 6B).

4.3 Quantitative analysis of ergot alkaloids
Table 2 displays comparisons of mean alkaloid accumulation in each strain ± standard
error. Festuclavine accumulated to significantly higher concentrations in the A. fumigatus easM
knockout than in the A. fumigatus wild type and easM complemented strains (P<0.05).
Fumigaclavine B production could be detected in A. fumigatus wild type and
complemented strains but was eliminated by the easM knock out. Quantities detected in wild
type and complemented strains do not differ significantly.
Fumigaclavine C was detected in the wild type and complemented strains but was lacking
in the easM knockout strain. The increase in concentration in the complemented strain suggests a
difference in regulation of the ectopically integrated gene.
The unknown chemical, hypothesized to be prenylated festuclavine (Figure 8) was
detected in all three strains. Knock out of easM resulted in a significant increase in concentration
of this compound. The complemented strain produced an intermediate amount of chemical, thus
not differing significantly from either wild type or from the knockout strain.
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5 Discussion
5.1 Role of EasM in the ergot alkaloid pathway
The pathway leading to the biosynthesis of lysergic acid is well established, but the
pathway to dihydrolysergic acid-derived ergot alkaloids has not been elucidated. The objective
of this study was to genetically manipulate steps in the ergot alkaloid pathway to prepare a strain
of A. fumigatus suitable for future investigations of the biosynthesis of dihydrolysergic acid
derived ergot alkaloids. Before exploring the dihydroergot alkaloid origin hypothesis, a
festuclavine accumulator needed to be obtained. This was done by knocking out the relevant
gene easM in the A. fumigatus ergot alkaloid pathway. Figure 4 illustrates the ergot alkaloid
synthesis pathway in A. fumigatus. Genes responsible for the production of enzymes advancing
each step of the pathway are indicated. However, the gene responsible for oxidizing festuclavine
into fumigaclavine B had not been characterized. Dr. Panaccione and I hypothesized that the
enzyme named EasM is responsible for oxidizing festuclavine to produce fumigaclavine B,
which is then converted into downstream derivatives (Figure 4) based on its capacity to encode a
P450 monooxygenase and its presence in the ergot alkaloid synthesis gene clusters of
fumigaclavine producers. PCR and HPLC results along with the statistical analysis of this
investigation described in the results section provide strong evidence that easM was successfully
knocked out and complemented. These results indicate that the enzyme encoded by easM is
necessary for oxidation of festuclavine into fumigaclavine B.

5.2 Differences in alkaloid quantity among wild type, knockout, and complemented strains
Table 2 shows a clear increase in the concentration of festuclavine and the putative
prenylated festuclavine in the knockout mutant, this occurs because in the absence of EasM the
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pathway cannot advance and the fungus accumulates festuclavine (Figure 4) a portion of which
becomes prenylated by easL. Other data in Table 2 may raise questions regarding the difference
in alkaloid quantities between the wild type and complemented strains of A. fumigatus. One
reason for the difference with higher quantities of alkaloid (fumigaclavine C and unknown
chemical) produced in the complemented strain, may be attributed to the fact that the integration
of the wild type easM gene into the complemented strain could not be controlled with precision.
During the transformation procedure relatively high concentrations of the wild type easM gene
were introduced into the protoplast mixture to facilitate higher probability of complementation.
Multiple copies of the wild type easM gene could have integrated into the genome. Additionally,
the integration locus may have affected the quantity of chemical the complemented fungus was
then able to produce, as some portions of the genome are more regulated than others. Thus the
quantity of easM genes and their integration loci may be the explanatory factors for the
difference in alkaloid quantity between the wild type and complemented A. fumigatus strains.
The transformation approach was chosen because it provided a reasonable strategy for
analysis of gene function. The knockout construct was prepared in a relatively quick cloning and
transformation procedure using a selectable marker, followed by a similar procedure for
complementation. Phenotypes associated with ectopic integration of genes along with selectable
markers could be reasonably differentiated via PCR and HPLC making this strategy a justifiable
means for observing gene function.
The uncharacterized compound that accumulated to higher concentrations in the easM
knockout strain of A. fumigatus (Figure 7 and 8) is hypothesized to be prenylated festuclavine.
Rationale for this prediction in that festuclavine accumulates in the easM knockout strain due to
the absence of a functional easM gene, the accumulated festuclavine may be utilized by an
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enzyme called EasL. EasL is a prenyl transferase whose typical function is to prenylate
fumigaclavine A converting it into fumigaclavine C (Unsöld and Li 2006; Robinson and
Panaccione 2012). Because fumigaclavine A is missing, due to the easM knockout (Figures 4
and 6) EasL may accept other substrates, in this case festuclavine, prenylating it into the
compound that eluted at 55.9 minutes (Figure 7) and had a molecular ion of 309.3 Da (Figure 8).
The ability of EasL to prenylate a variety of ergot alkaloids has been observed in previous
studies (Ge et al. 2009; Robinson and Panaccione 2014).
Fumigaclavines A and B are intermediates between festuclavine and fumigaclavine C
(Figure 4). Fumigaclavine A was not detected (Figure 7 and Table 2) in any of the strains used in
this study. Absence of fumigaclavine A may be explained via function of EasL which converts
fumigaclavine A to fumigaclavine C (Unsöld and Li 2006; Robinson and Panaccione 2012).
Small quantities of fumigaclavine B were detected because the enzyme EasN had not yet
converted fumigaclavine B to fumigaclavine A.

5.3 Additional studies and future directions
A. fumigatus, a fumigaclavine producer, and lysergic acid producers like Claviceps spp.
and Epichloë spp. differ in their allele for easA within the ergot alkaloid pathway (Coyle et al.
2010). Epichloë sp. Lp1 CloA typically accepts agroclavine as its substrate and turns it into
lysergic acid through a series of oxidations and a double bond isomerization (Robinson and
Panaccione 2014). Expressing Epichloë sp. Lp1 cloA in an A. fumigatus festuclavine
accumulator may test whether Epichloë sp. Lp1 CloA is able to accept festuclavine and turn it
into dihydrolysergic acid. Agroclavine and festuclavine differ in their structure only by the
presence or absence of a double bond in the D ring (Figure 3). One hypothesis is that easA is the
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only significant difference between dihydrolysergic and lysergic acid producers, with
downstream enzymes in dihydrolysergic acid producers performing the same functions they do
in lysergic acid producers.
Preliminary exploration of expressing an Epichloë cloA gene from an easA A. fumigatus
promotor did not yield desirable results. The purpose of expressing cloA in an A. fumigatus
festuclavine-accumulating strain was to test whether Epichloë sp. Lp1 native CloA, which
typically modifies agroclavine into lysergic acid, would operate similarly in an A. fumigatus
festuclavine-accumulating strain to produce dihydrolysergic acid. The core of lysergic and
dihydrolysergic acid only differs by the presence of a double bond (Figure 5); festuclavine also
possesses this same core (lacking a double bond) which may allow it to serve as a suitable
substitute for the agroclavine substrate. Thus, CloA should add on functional groups in the two
subsequent steps to make dihydrolysergic acid instead of the typical lysergic acid product
(Figure 3). Additionally, evidence exists for permissiveness in substrate recognition in
downstream enzymes; for example, LPS2 (Figure 3) in Claviceps purpurea has the ability to
accept dihydrolysergic acid as well as lysergic acid as substrates (Riederer et al. 1996). This
provides additional evidence that the enzymes of lysergic acid producing fungi have the ability to
accept dihydrolysergic acid precursors. Epichloë sp. Lp1 cloA was expressed by fusing its coding
sequences to the A. fumigatus easA promoter and the construct was transformed into the A.
fumigatus festuclavine-accumulating strain. Conversion of festuclavine to lysergic acid was
investigated via HPLC. Of the nineteen resulting transformants, integration of DNA was evident
via PCR, but HPLC results did not indicate production of dihydrolysergic acid derivatives.
Additionally, a feeding study testing the transformants ability to use exogenously supplied
agroclavine and elymoclavine as substrates indicated that CloA was not utilizing the substrates
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for conversion to downstream products. There are many reasons why the expression of cloA may
not have worked: damaged DNA, integration of construct at a non-ideal site in the genome, lack
of affinity for festuclavine (a dihydrolysergic acid precursor) as a suitable substrate, or perhaps a
combination of native alleles (easA and cloA) are needed to make festuclavine work as a
substrate for conversion to lysergic derivatives. Several fungi including A. fumigatus and
Epichloë sp. have easA genes but their alleles differ. This may mean that the easA and cloA
alleles from Epichloë may need to be transformed into A. fumigatus, as opposed to utilizing cloA
from Epichloë sp. Lp1 and letting A. fumigatus utilize its own easA. Additional attempts have
been made in utilizing easA and cloA from the same fungus, namely Epichloë but transformants
did not result in desirable HPLC profiles. I suggest that future studies attempt to express other
alleles of easA and cloA in the A. fumigatus festuclavine accumulator in an attempt to convert
festuclavine to dihydrolysergic acid.

5.4 Conclusion
The ergot alkaloid synthesis cluster gene easM encodes a P450 monooxygenase that is
necessary for oxidizing festuclavine into fumigaclavine B. Elucidating easM function is
important as it adds to our knowledge of the ergot alkaloid pathway. Because easM had been
sequenced but not yet characterized, this project provides evidence for easM’s function which
had previously not been documented. Moreover, the engineering of a festuclavine accumulating
A. fumigatus strain is instrumental in the next phase of research for the biosynthesis of
dihydrolysergic acid. Dihydrolysergic acid derivatives are vasorelaxant and are the active
compounds in drugs that help treat disorders like dementia, and Alzheimer’s. Agricultural
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applications for dihydroergot alkaloid producers which may counteract natural lysergic acid
producing grass endophytes also exist.
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Figures and Tables

	
  

Figure 1: Divergence of the ergot alkaloid pathway at the chanoclavine-I aldehyde branch point.
Note: Asexual Epichloë spp. were previously called Neotyphodium spp. The figure was modified
from Panaccione et al. (2012).
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Figure 2: Ergot alkaloid synthesis gene cluster of A. fumigatus (A) redrawn from Coyle and
Panaccione (2005). Epichloë sp. Lp1 ergot alkaloid synthesis cluster (B) redrawn from Schardl et
al. (2013). Compressed regions are designated with hash marks to allow for concise presentation.
Arrows indicate direction of transcription. Functions have been assigned for all genes other than
easM and easK.
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Figure 3: Ergot alkaloid pathway reproduced from Robinson & Panaccione (2014).
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Figure 4: Ergot alkaloid pathway in A. fumigatus, showing genes (above corresponding arrows)
responsible for each step (Panaccione 2010).
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Figure 5: Lysergic acid and dihydrolysergic acid. The chemicals are the same except
dihydrolysergic acid lacks a double bond in one of its rings.
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Figure 6: (A) Schematic representation of easM locus in A. fumigatus before and after gene
knock out. (B) PCR products of A. fumigatus isolate Af293 wild type, easM knockout, and easM
complemented strains. Wild type screen is checking for the easM fragment. Three prime screen
was primed with primers that anneal beyond the 3’ end of easM and the middle of the
hygromycin resistance gene. Five prime screen was primed with oligonucleotides that anneal
before the 5’ end of easM and in the middle of the hygromycin resistance gene.
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Figure 7: High performance liquid chromatography (HPLC) results illustrating ergot alkaloid
accumulation in wild type, easM knock out, and complemented A. fumigatus strains. Data were
collected with a fluorescence detector (excitation 272 nm/emission 372 nm). Festuclavine eluted
from the column at 41.9 minutes, fumigaclavine C eluted at 59 minutes, and a partially
characterized compound (putative prenylated festuclavine; designated with an asterisk) eluted at
55.9 minutes.
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Figure 8: Mass spectrum and predicted structure of chemical accumulating to higher
concentrations in the A. fumigatus easM knockout strain.
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Table 1 PCR primers used in this study and their products.
Primer
Primer sequence 5’ à 3’
combination
easMF +
GCCATTCCTCCACTCTTCAG +
easMR
CCAAAGAACATTCCCAGCTC
easNtowardM+
YG

GACTGCCAGTATCATCTACC +
CGTTGCAAGACCTGCCTGAA

easDinF +
HY

ACTGCGCTACAGTCGATGTAAC +
GGATGCCTCCGCTCGAAGTA

Product

Amplicon
length (bp)

easM

3,067

3’ flank of
integrated
ko construct
5’ flank of
integrated
ko construct

2,057
2,916
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Table 2 Mean alkaloid concentration (mean amol/spore ± standard error; n = 6) in A. fumigatus
wild type, easM knockout, and easM complemented strains. Within each column, designation
with different letters indicates significant difference (α=0.05) in a Tukey-Kramer HSD test (or
one-way ANOVA, when alkaloid detected in two strains).

a
b

Strain

Festuclavine

Fumigaclavine B

Fumigaclavine C

Unknownª

A. fumigatus Af293
wild type

6.30 ± 4.92 A

0.58 ± 0.09 A

8.83 ± 1.37 A

1.19 ± 0.90 A

A. fumigatus Af293
easM knockout

33.59 ± 9.19 B

n.d.b

n.d.

8.39 ± 3.14 B

A. fumigatus Af293
easM complemented

13.91 ± 6.38 A

0.35 ± 0.05 A

23.12 ± 3.90 B

4.64 ± 3.72 AB

putative prenylated festuclavine
not detected; limit of detection = 0.01 amol/spore.
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